Publication Topic

Beebe-Dimmer J, Schwartz KA, Cetin K, Morgenstern H, Yee C, Bartoces M, Shahinian V, Fryzek J, Acquavella J. Incidence of cataract among elderly prostate cancer patients receiving androgen deprivation therapy in the United States using the Surveillance, Epidemiology, and End Results-Medicare database. Presented at the American Society of Clinical Oncology (ASCO) Annual Conference, June 9-11, 2010, Chicago, IL.

Du Y, Fryzek J, Sekeres MA, Taioli E. 2010. Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res 34(1):1-5.

Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K. 2009. The epidemiology of malignant giant cell tumors of bone: An analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004). Rare Tumors 1(2):e52.

Kelsh MA, Morimoto L, Lau E. Cancer mortality and oil production in the Amazon region of Ecuador. 2009. Int Arch Occup Environ Health 82(3): 381–395.

Jensen AØ, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. 2009. Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of Patients. Clin Epidemiol 1:101-108.

Gatto N, Kelsh M, HaMai D, Suh M, Proctor D. A meta-analysis of the relationship between occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract. Society of Toxicology 48th Annual Meeting, Baltimore, MD, March 2009.

Thomsen RW, Thomsen HF, Nørgaard M, Cetin K, McLaughlin JK, Tarone RE, Fryzek JP, Sørensen HT. 2008. Risk of cholecystitis in patients with cancer: A population-based cohort study in Denmark. Cancer 113(12):3410-3419.

Sekeres MA, Schoonen WM, Kantarjian H, List A, Fryzek J, Paquette R, Maciejewski JP. 2008. Characteristics of US patients with myelodysplastic syndromes: Results of six cross-sectional physician surveys. J Natl Cancer Inst 100(21):1542-1551.

Kelsh MA, Alexander DD, Kalmes RM, Buffler PA. 2008. Personal use of hair dyes and risk of bladder cancer: A meta-analysis of epidemiologic data. Cancer Causes Control 19(6):549–558.

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. 2008. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310.